SEC Filing Details

SEC Filing Details

Document Details

Form
425
Filing Date
Jan 20, 2021
Document Date
Jan 20, 2021
Form Description
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Group
Other
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE